DrugPatentWatch Database Preview
Indacaterol maleate - Generic Drug Details
What are the generic sources for indacaterol maleate and what is the scope of indacaterol maleate patent protection?
Indacaterol maleate has eighty-four patent family members in thirty-eight countries.
Two suppliers are listed for this compound.
Summary for indacaterol maleate
| International Patents: | 84 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 73 |
| Clinical Trials: | 265 |
| Patent Applications: | 42 |
| Drug Prices: | see low prices |
| DailyMed Link: | indacaterol maleate at DailyMed |
Pharmacology for indacaterol maleate
| Drug Class | beta2-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta2-Agonists |
Synonyms for indacaterol maleate
| (6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H- pyrido(3,2-b)-1,4-oxazin-4-yl)methyl dihydrogen phosphate |
| (R)-5-(2-(5,6-diethyl-2,3-dihydro-1H-inden-2-ylamino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
| (R)-5-[2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one |
| 2(1H)-Quinolinone,5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy- |
| 2474AH |
| 2JEC1ITX7R |
| 312753-06-3 |
| 435273-74-8 |
| 5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one |
| 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1,2-dihydroquinolin-2-one |
| 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one |
| 5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-2(1H)-quinolinone Maleic Acid |
| 5-[(1R)-2-[(5,6-DIETHYL-2,3-DIHYDRO-1H-INDEN-2-YL)AMINO]-1-HYDROXYETHYL]-8-HYDROXYQUINOLIN-2(1H)-ONE |
| 5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one; QAB 149 |
| 5-[(1R)-2-[(5,6-diethylindan-2-yl)amino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one |
| 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1h-quinolin-2-one |
| 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one maleate |
| 5-{(1R)-2-((5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl}-8-hydroxyquinolin-2(1H)-one |
| 5-{(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl}-8-hydroxyquinolin-2(1H)-one |
| 5-{(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl}-8-hydroxyquinolin-2(1H)-one (2Z)-but-2-enedioate |
| 5,6-diethyl-N-[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]indan-2-aminium (2Z)-3-carboxyacrylate |
| 753498-25-8 |
| 753I063 |
| 8-Hydroxy-5-[(R)-1-hydroxy-2-(5,6-diethylindan-2-ylamino)-ethyl]-1H-quinolin-2-one |
| 870265-20-6 |
| 8OR09251MQ |
| AB0073003 |
| AB01565805_02 |
| ABP001015 |
| AC-27668 |
| AC1OCFKW |
| AJ-92125 |
| AK160051 |
| AK163936 |
| AKOS024463516 |
| AKOS024464878 |
| AKOS030228638 |
| AN-488 |
| API0008161 |
| Arcapta |
| Arcapta Neohaler |
| Arcapta neohaler (TN) |
| AS-10152 |
| AX8161417 |
| BCP0726000140 |
| BCP9000787 |
| BDBM50318159 |
| C24H28N2O3.C4H4O4 |
| CHEBI:68573 |
| CHEBI:68575 |
| CHEMBL1095777 |
| CHEMBL1789842 |
| CS-0744 |
| CS-2703 |
| D03DJL |
| D03VWV |
| D09318 |
| D09319 |
| DB05039 |
| DTXSID90185198 |
| FT-0686953 |
| FT-0773084 |
| GTPL7455 |
| Hirobriz Breezhaler |
| HY-14299 |
| HY-14299A |
| I0927 |
| Indacaterol |
| Indacaterol (maleate) |
| Indacaterol (USAN/INN) |
| Indacaterol [USAN:INN:BAN] |
| Indacaterol maleate (JAN/USAN) |
| Indacaterol maleate [USAN] |
| Indacaterol Maleic Acid Salt |
| Indacaterol/mometasone |
| IREJFXIHXRZFER-PCBAQXHCSA-N |
| J-521526 |
| KB-77887 |
| KS-00000SPP |
| MFCD18782702 |
| MFCD20526769 |
| MolPort-023-219-171 |
| MolPort-035-395-723 |
| Onbrez |
| Onbrez Breezhaler |
| Onbrez Inhalation Capsules |
| Oslif Breezhaler |
| Q-4501 |
| QAB 149 |
| QAB 149 Maleic Acid |
| QAB 149AFA |
| QAB-149 |
| QAB-149 maleate |
| QAB-149-AFA |
| QAB149 |
| QAB149-AFA |
| QABI49 |
| QMF149 |
| QZZUEBNBZAPZLX-QFIPXVFZSA-N |
| RL03096 |
| S3083 |
| SC-90142 |
| SCHEMBL48098 |
| SCHEMBL523627 |
| UNII-2JEC1ITX7R |
| UNII-8OR09251MQ |
| W9904 |
| ZINC35801098 |
US Patents and Regulatory Information for indacaterol maleate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunovion Pharms Inc | ARCAPTA NEOHALER | indacaterol maleate | POWDER;INHALATION | 022383-001 | Jul 1, 2011 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Sunovion Pharms Inc | ARCAPTA NEOHALER | indacaterol maleate | POWDER;INHALATION | 022383-001 | Jul 1, 2011 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Sunovion Pharms Inc | ARCAPTA NEOHALER | indacaterol maleate | POWDER;INHALATION | 022383-001 | Jul 1, 2011 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Sunovion Pharms Inc | ARCAPTA NEOHALER | indacaterol maleate | POWDER;INHALATION | 022383-001 | Jul 1, 2011 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for indacaterol maleate
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,283,362 | Beta-2-adrenoreceptor agonists | ➤ Sign Up |
| 8,436,017 | Beta-2-adrenoreceptor agonists | ➤ Sign Up |
| 7,622,483 | .beta.2-adrenoceptor agonists | ➤ Sign Up |
| 9,040,559 | BETA2-adrenoceptor agonists | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for indacaterol maleate
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Peru | 02192001 | ➤ Sign Up |
| European Patent Office | 2332915 | ➤ Sign Up |
| Denmark | 1183240 | ➤ Sign Up |
| Czech Republic | 20014301 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for indacaterol maleate
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0006 | France | ➤ Sign Up | PRODUCT NAME: INDACATEROL OU UN SEL DE CELUI-CI; REGISTRATION NO/DATE IN FRANCE: EU/1/09/593/001 DU 20091130; REGISTRATION NO/DATE AT EEC: EU/1/09/593/001-010 DU 20091130 |
| C009/2010 | Ireland | ➤ Sign Up | SPC009/2010: 20100813, EXPIRES: 20241129 |
| 2014 00020 | Denmark | ➤ Sign Up | PRODUCT NAME: GLYCOPYRRONIUM ELLER ET SALT DERAF, ISAER BROMIDSALTET, I KOMBINATION MED INDACATEROL ELLER ET SALT DERAF, ISAER MALEATSALTET; REG. NO/DATE: EU/1/13/862 20130919 |
| C/GB10/009 | United Kingdom | ➤ Sign Up | PRODUCT NAME: INDACATEROL OR A SALT THEREOF; REGISTERED: UK EU/1/09/593/001 20091130; UK EU/1/09/593/002 20091130; UK EU/1/09/593/003 20091130; UK EU/1/09/593/004 20091130; UK EU/1/09/593/005 20091130; UK EU/1/09/593/006 20091130; UK EU/1/09/593/007 20091130; UK EU/1/09/593/008 20091130; UK EU/1/09/593/009 20091130; UK EU/1/09/593/010 20091130 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Get our Free Drug Patent Bulletin
Join the 27,111 others who get our Drug Patent Expiration Alerts:
- Articles on vital topics
- Fresh industry trends
- Expiring drug patents
- More …
